Fra(10)(q25): the BrdU Effect is Substitution-dependent

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 1985 Jan 1

PMID 3976659

Authors

S M Gollin

G P Holmquist

D H Ledbetter

Affiliations

Soon will be listed here.

Abstract

Expression in the majority of fra(10)(q25) cases is either induced or enhanced by the presence of bromodeoxyuridine (BrdU) in the culture medium. BrdU is known to exert its effects on cells via two primary mechanisms: substitution-dependent and concentration-dependent. BrdU incorporation into DNA and BrdU concentration in the culture medium can be resolved as independent variables. The results of such experiments indicate that at three fixed levels of BrdU substitution, 100-fold variation of BrdU concentration had little or no effect on fra(10)(q25) expression. At a fixed BrdU concentration, the level of fra(10)(q25) expression rises as a function of increased BrdU substitution, approaching 100% expression at 100% substitution. Thus, BrdU induction or enhancement of fra(10)(q25) expression is clearly substitution-dependent. Iododeoxyuridine, another halogenated pyrimidine, has a similar effect. The critical time of incorporation is between 8 and 9 hrs before mitosis. After this time, removal of BrdU (and fluorodeoxyuridine [FdU]) from the culture medium followed by addition of deoxythymidine does not reverse the BrdU effect on fra(10)(q25) expression.

References

Goz B . The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells. Pharmacol Rev. 1977; 29(4):249-72. View

Davidson R, KAUFMAN E . Bromodeoxyuridine mutagenesis in mammalian cells is stimulated by thymidine and suppressed by deoxycytidine. Nature. 1978; 276(5689):722-3. DOI: 10.1038/276722a0. View

KAUFMAN E, Davidson R . Bromodeoxyuridine mutagenesis in mammalian cells: mutagenesis is independent of the amount of bromouracil in DNA. Proc Natl Acad Sci U S A. 1978; 75(10):4982-6. PMC: 336246. DOI: 10.1073/pnas.75.10.4982. View

Davidson R, KAUFMAN E, Dougherty C, Ouellette A, DiFolco C, LATT S . Induction of sister chromatid exchanges by BUdR is largely independent of the BUdR content of DNA. Nature. 1980; 284(5751):74-6. DOI: 10.1038/284074a0. View

ASHMAN C, Davidson R . Inhibition of Friend erythroleukemic cell differentiation by bromodeoxyuridine: correlation with the amount of bromodeoxyuridine in DNA. J Cell Physiol. 1980; 102(1):45-50. DOI: 10.1002/jcp.1041020107. View

Sutherland G, Baker E, Seshadri R . Heritable fragile sites on human chromosomes. V. A new class of fragile site requiring BrdU for expression. Am J Hum Genet. 1980; 32(4):542-8. PMC: 1686118. View

ASHMAN C, Davidson R . Bromodeoxyuridine mutagenesis in mammalian cells is related to deoxyribonucleotide pool imbalance. Mol Cell Biol. 1981; 1(3):254-60. PMC: 369669. DOI: 10.1128/mcb.1.3.254-260.1981. View

Sutherland G, Baker E, Mulley J . Genetic length of a human chromosomal segment measured by recombination between two fragile sites. Science. 1982; 217(4557):373-4. DOI: 10.1126/science.7089572. View

Taylor A, Bundey S . Spontaneous expression of the chromosome fragile site fra(10)(q25). Am J Hum Genet. 1983; 35(1):123-5. PMC: 1685496. View

10.

Petit P, Fryns J . Expression of fragile site at 10q25 in normal culture conditions. Am J Hum Genet. 1983; 35(1):126-7. PMC: 1685484. View

11.

Hanks S, Gollin S, Rao P, Wray W, Hittelman W . Cell cycle-specific changes in the ultrastructural organization of prematurely condensed chromosomes. Chromosoma. 1983; 88(5):333-42. DOI: 10.1007/BF00285856. View

12.

Sutherland G, Jacky P, Baker E . Heritable fragile sites on human chromosomes. XI. Factors affecting expression of fragile sites at 10q25, 16q22, and 17p12. Am J Hum Genet. 1984; 36(1):110-22. PMC: 1684393. View

13.

Anneren G, GUSTAVSON K . A fragile secondary constriction on chromosome 2 in five patients with different clinical features. Hereditas. 1981; 95(1):63-7. DOI: 10.1111/j.1601-5223.1981.tb01329.x. View